Core IM | Internal Medicine Podcast cover image

#192 Debate on First-Line Medications for Diabetes

Core IM | Internal Medicine Podcast

00:00

Evidence Depth: SGLT2s for Kidney Outcomes

Keri emphasizes the stronger and broader evidence supporting SGLT2 inhibitors for CKD outcomes compared with GLP-1s.

Play episode from 35:29
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app